Harveen Sethi Joins Claremont Creek Ventures as Associate

Ted Driscoll

Harveen Sethi

I am excited to announce today that Harveen Sethi has joined the CCV team as an associate. She will be working closely with Brad Webb and me. Harveen is passionate about impactful disruptive innovation, especially in shaping the next frontier of healthcare. She is particularly enthusiastic about the potential of big data analytics and technology in advancing predictive diagnostics and personalized medicine. These are sweet spots for CCV. Brad and I . . .
→ Read full post: Harveen Sethi Joins Claremont Creek Ventures as Associate

Ted Driscoll’s WSJ interview: 23andMe Flap With FDA Just a Bump in the Road, One Genetics-Testing Investor Says

WallStreetJournalLogo

source: by Timothy Hay

When the Food and Drug Administration told personal-genetics company 23andMe Inc. in November to stop sending consumers detailed information about their DNA, some industry watchers said the move could be a devastating blow to an emerging area of medicine that holds promise for better health outcomes.

But it was more of a flesh wound, said Claremont Creek Ventures Director Ted Driscoll. Though not an investor in 23andMe, he has . . .
→ Read full post: Ted Driscoll’s WSJ interview: 23andMe Flap With FDA Just a Bump in the Road, One Genetics-Testing Investor Says